Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth R Lawlor

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology GroupJohn A van Doorninck, Lingyun Ji, Betty Schaub, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2010
Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology GroupAaron Cooper, John van Doorninck, Lingyun Ji, et al.
Oncotarget|November 27, 2016
Tumorigenicity of Ewing sarcoma is critically dependent on the trithorax proteins MLL1 and meninLaurie K Svoboda, Natashay Bailey, Raelene A Van Noord, et al.
Cancer|November 13, 2014
Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survivalJason U Tilan, Mark Krailo, Donald A Barkauskas, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2015
Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicingSaravana P Selvanathan, Garrett T Graham, Hayriye V Erkizan, et al.
Pediatric Blood & Cancer|May 6, 2008
Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor CommitteeJames S Meyer, Helen R Nadel, Neyssa Marina, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Multimodal single-cell analyses reveal distinct fusion-regulated transcriptional programs in Ewing sarcomaOlivia G Waltner, April A Apfelbaum, Emma D Wrenn, et al.
Science Advances|January 21, 2026
Autocrine TGFβ2 enforces a transcriptionally hybrid cell state in Ewing sarcomaEmma D Wrenn, Jacob C Harris, April A Apfelbaum, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Autocrine TGFβ2 enforces a transcriptionally hybrid cell state in Ewing sarcomaEmma D Wrenn, Jacob C Harris, April A Apfelbaum, et al.
Molecular Cancer Therapeutics|November 13, 2016
Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing MelanomaAndrew J Haak, Kathryn M Appleton, Erika M Lisabeth, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology GroupJohn A van Doorninck, Lingyun Ji, Betty Schaub, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2010
Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology GroupAaron Cooper, John van Doorninck, Lingyun Ji, et al.
Oncotarget|November 27, 2016
Tumorigenicity of Ewing sarcoma is critically dependent on the trithorax proteins MLL1 and meninLaurie K Svoboda, Natashay Bailey, Raelene A Van Noord, et al.
Cancer|November 13, 2014
Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survivalJason U Tilan, Mark Krailo, Donald A Barkauskas, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2015
Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicingSaravana P Selvanathan, Garrett T Graham, Hayriye V Erkizan, et al.
Pediatric Blood & Cancer|May 6, 2008
Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor CommitteeJames S Meyer, Helen R Nadel, Neyssa Marina, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Multimodal single-cell analyses reveal distinct fusion-regulated transcriptional programs in Ewing sarcomaOlivia G Waltner, April A Apfelbaum, Emma D Wrenn, et al.
Science Advances|January 21, 2026
Autocrine TGFβ2 enforces a transcriptionally hybrid cell state in Ewing sarcomaEmma D Wrenn, Jacob C Harris, April A Apfelbaum, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Autocrine TGFβ2 enforces a transcriptionally hybrid cell state in Ewing sarcomaEmma D Wrenn, Jacob C Harris, April A Apfelbaum, et al.
Molecular Cancer Therapeutics|November 13, 2016
Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing MelanomaAndrew J Haak, Kathryn M Appleton, Erika M Lisabeth, et al.
Pageof 8